NASDAQ

Aquinox Pharmaceuticals Announces First Quarter 2016 Financial Results

VANCOUVER, British Columbia, May 10, 2016 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), ...

ChemoCentryx Reports First Quarter 2016 Financial Results and Provides Corporate Update

- Company Announces Exclusive License Agreement with Vifor Pharma to Commercialize Orally Administered Complement ...

Biotricity Establishes Board of Advisors

REDWOOD CITY, Calif., May 10, 2016 (GLOBE NEWSWIRE) -- Biotricity, Inc. (OTCQB:BTCY), a healthcare technology ...

Idera Pharmaceuticals Reports First Quarter 2016 Financial Results and Provides Corporate Update

9 of 10 Waldenstrom’s Macroglobulinemia Patients Treated at the Highest Dose have Demonstrated Reductions ...

Coherus BioSciences Reports First Quarter 2016 Financial and Operating Results

CHS-1420 (adalimumab biosimilar) Formulation Patents to Issue in MayCompleted Private Convertible Financing of $100 ...

Oncothyreon Reports First Quarter 2016 Financial Results & Provides Corporate Update

SEATTLE, May 09, 2016 (GLOBE NEWSWIRE) -- Oncothyreon Inc. (NASDAQ:ONTY), a clinical-stage biopharmaceutical company, ...

Fate Therapeutics Reports First Quarter 2016 Financial Results

Phase 1/2 Clinical Trial of ProTmune™ for Prevention of Acute GvHD and CMV Infection ...